Following this activity, participants should be able to: (1) Describe the epidemiology, pathobiology, and prognostic features of mantle cell lymphoma; (2) Discuss the changing role of chemoimmunotherapy followed by autologous stem cell transplantation (ASCT) in the front-line setting; and (3) Outline the second line and subsequent therapy options immunotherapeutics and non-covalent BTKis that can be considered for patients who experience progression during or following covalent BTKis.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 3025 Chemical Road
Pricing
CME included with membership
| Free CME Activity | Free |
| Paid Activity (e.g. Breast/Lung Cancer Congress recordings) | $50 |
| Paid Activity (e.g. Hematologic Malignancies Congress recording) | $90 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Anatomic & Clinical Pathology
- Colon & Rectal Surgery
- Communication & Shared Decision-Making
- Dermatopathology
- Evidence-Based Medicine & Research
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pain Medicine
- Pediatric Hematology-Oncology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Primary care
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedDec 19, 2025
-
Last day to claim creditDec 18, 2026 2 months left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing Mantle Cell Lymphoma Care: Case-Based Guidance From EU Experts
-
Plexus Communications +1 Bringing BTK Inhibitors to the Frontline Setting: Essential Advancements in Mantle Cell Lymphoma Management
-
PRIME Education, Inc. (PRIME®) Expert Perspectives in PTCL Management: Current Standards and Emerging Therapies
-
National Comprehensive Cancer Network Recorded Presentation from the NCCN 2026 Annual Conference: Hematologic Malignancies
-
National Comprehensive Cancer Network Recorded Presentation from Optimizing Patient Outcomes – When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia
-
National Comprehensive Cancer Network Recorded Presentation from Optimizing Patient Outcomes – In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric Acute Lymphoblastic Leukemia
